Robeco Institutional Asset Management B.V. boosted its stake in Northrop Grumman Corporation (NYSE:NOC – Free Report) by 10.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 96,123 shares of the aerospace company’s stock after purchasing an additional 8,727 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Northrop Grumman were worth $46,474,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Diversify Advisory Services LLC lifted its position in shares of Northrop Grumman by 20.1% during the 3rd quarter. Diversify Advisory Services LLC now owns 2,487 shares of the aerospace company’s stock valued at $1,242,000 after buying an additional 416 shares in the last quarter. 55 North Private Wealth LLC grew its stake in Northrop Grumman by 31.1% during the third quarter. 55 North Private Wealth LLC now owns 586 shares of the aerospace company’s stock valued at $283,000 after acquiring an additional 139 shares in the last quarter. Kenora Financial LLC increased its holdings in shares of Northrop Grumman by 2.8% in the third quarter. Kenora Financial LLC now owns 7,297 shares of the aerospace company’s stock worth $3,528,000 after purchasing an additional 199 shares during the last quarter. CFS Investment Advisory Services LLC increased its stake in Northrop Grumman by 30.9% in the 3rd quarter. CFS Investment Advisory Services LLC now owns 636 shares of the aerospace company’s stock worth $307,000 after acquiring an additional 150 shares during the last quarter. Finally, Retirement Planning Group LLC increased its position in Northrop Grumman by 8.4% in the third quarter. Retirement Planning Group LLC now owns 1,401 shares of the aerospace company’s stock worth $677,000 after purchasing an additional 108 shares during the last quarter. 83.40% of the stock is currently owned by institutional investors.
Insider Activity
In related news, Director Mark Welsh, III sold 95 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $547.53, for a total transaction of $52,015.35. Following the completion of the sale, the director directly owned 4,393 shares in the company, valued at approximately $2,405,299.29. The trade was a 2.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.21% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. Royal Bank Of Canada upped their price objective on Northrop Grumman from $525.00 to $550.00 and gave the company a “sector perform” rating in a research report on Wednesday. Wells Fargo & Company reaffirmed an “overweight” rating and set a $620.00 target price (down from $800.00) on shares of Northrop Grumman in a research report on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft set a $615.00 price target on Northrop Grumman and gave the company a “buy” rating in a research note on Wednesday, July 22nd. TD Cowen decreased their price target on shares of Northrop Grumman from $590.00 to $540.00 and set a “hold” rating for the company in a research report on Friday, October 9th. Finally, UBS Group raised their price target on Northrop Grumman from $694.00 to $698.00 and gave the stock a “buy” rating in a report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $641.83.
View Our Latest Stock Analysis on Northrop Grumman
Northrop Grumman Trading Up 2.5%
Northrop Grumman stock opened at $552.82 on Friday. Northrop Grumman Corporation has a 12 month low of $470.06 and a 12 month high of $774.00. The company has a current ratio of 1.23, a quick ratio of 1.06 and a debt-to-equity ratio of 0.77. The firm has a market cap of $78.53 billion, a PE ratio of 18.64, a P/E/G ratio of 3.08 and a beta of -0.11. The stock’s 50 day simple moving average is $521.83 and its two-hundred day simple moving average is $547.91.
Northrop Grumman (NYSE:NOC – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The aerospace company reported $7.89 earnings per share for the quarter, beating the consensus estimate of $7.18 by $0.71. Northrop Grumman had a return on equity of 23.46% and a net margin of 10.37%. The firm had revenue of $11.12 billion during the quarter, compared to analyst estimates of $11.14 billion. During the same quarter in the previous year, the business earned $7.67 EPS. Northrop Grumman’s revenue for the quarter was up 6.7% compared to the same quarter last year. Analysts anticipate that Northrop Grumman Corporation will post 29.51 earnings per share for the current year.
Northrop Grumman Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 16th. Investors of record on Monday, August 31st were issued a $2.47 dividend. This represents a $9.88 annualized dividend and a yield of 1.8%. The ex-dividend date was Monday, August 31st. Northrop Grumman’s payout ratio is presently 31.17%.
Northrop Grumman News Summary
Here are the key news stories impacting Northrop Grumman this week:
- Positive Sentiment: Q3 earnings beat and guidance raise: Northrop Grumman reported adjusted earnings of $7.89 per share, well above the $7.18 consensus estimate. Management raised its fiscal 2026 adjusted EPS outlook to $29.35-$29.75, compared with the $28.97 analyst consensus, while revenue guidance of $43.8 billion-$44.3 billion remained broadly in line with expectations. NOC’s Q3 Earnings Call Highlights 2027 Growth and B-21 Spending
- Positive Sentiment: Record backlog supports future revenue: Backlog reached approximately $109.6 billion-$110 billion, up about 20% year over year. Investors viewed the backlog as evidence of strong demand across Northrop’s defense and space businesses, including the B-21 program. Management is targeting 5%-7% sales growth in 2027. Q3 2026 Earnings Call Highlights
- Positive Sentiment: Analyst sentiment improved: Robert W. Baird upgraded NOC from Hold to Outperform and raised its price target to $675 from $550. BNP Paribas Exane also lifted its target to $600 and maintained an Outperform rating, citing the “beat and raise” quarter and longer-term growth prospects. Northrop Grumman Analysts Boost Their Forecasts
- Neutral Sentiment: Investor focus remains on execution: The earnings discussion highlighted multi-year growth opportunities and strong defense demand, while the AUSA 2026 interview provided additional management visibility. However, RBC only raised its target to $550 and kept a Sector Perform rating, indicating that some analysts view the favorable outlook as already reflected in the shares.
- Negative Sentiment: Spending and margin risks persist: Higher capital expenditures, B-21 investment requirements, margin pressure, and paused buybacks could limit near-term cash returns and create execution challenges despite the strong backlog. Are RTX Corporation and Northrop Grumman Ready to Break Out?
About Northrop Grumman
Northrop Grumman Corporation (NYSE:NOC) is a global aerospace and defense company that develops and produces systems for government and commercial customers, with the U.S. government representing its primary customer base. The company operates across aerospace, defense, space, cybersecurity and advanced technology markets.
Its products and services include military aircraft and autonomous systems, space systems and satellites, missile defense technologies, command-and-control systems, cyber solutions, sensors, communications networks and other mission-critical systems.
Featured Articles
- Five stocks we like better than Northrop Grumman
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Want to see what other hedge funds are holding NOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Northrop Grumman Corporation (NYSE:NOC – Free Report).
Receive News & Ratings for Northrop Grumman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northrop Grumman and related companies with MarketBeat.com's FREE daily email newsletter.
